Dan Dolan | CFO |
Ted Schroeder | CEO |
Carl Byrnes | Northland Capital Markets |
Thomas Yip | HCW |
Good morning, and welcome to the Nabriva Therapeutics Second Quarter 2022 Financial Results Conference Call. [Operator Instructions] Please note that this event is being recorded today. I would now like to turn the conference over to Dan Dolan. Please go ahead, sir.
Thank you, and good afternoon, everyone.